Select Publications
Conference Papers
2022, 'Developing the New South Wales surveillance plan for Australia's kava pilot', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S35 - S35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Drug related harms and responses at New South Wales music festivals: Then, now and where to next', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S12 - S13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'New South Wales medical and toxicity surveillance for drug related harms in music festival settings', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S14 - S14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Moderate neurotoxicity from topically applied lidocaine cream', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000794992600089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prescribing implications of estimating renal function with Creatinine vs Cystatin C in a geriatric inpatient population', in AUSTRALASIAN JOURNAL ON AGEING, WILEY, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651084100053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prescribing implications of measured concentrations of apixaban in a geriatric inpatient population', in AUSTRALASIAN JOURNAL ON AGEING, WILEY, pp. 26 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651084100037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'QUANTIFYING THE IMPACT OF ACUTE AND CHRONIC KIDNEY DYSFUNCTION ON THE EFFECT OF IDARUCIZUMAB', in NEPHROLOGY, WILEY, pp. 55 - 55, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Accelerated idioventricular rhythm with recreational 1,4-butanediol overdose', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 574 - 574, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531053300161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Pharmacokinetic modelling for anticipating an incomplete response to the recommended dose of idarucizumab', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 553 - 553, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531053300121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Use of laboratory tests for identifying patients at risk of an incomplete response to the recommended dose of idarucizumab', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 631 - 632, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531053300281&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Acute 1,4-butanediol ingestion can mimic toxic alcohol poisoning', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 1191 - 1191, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000500830800077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Cost-assessment of the use of fomepizole for the treatment of toxic alcohol poisonings in Australian practice', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 1202 - 1203, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000500830800106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Improving the regional management of mushroom exposures by a Poisons Information Centre', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 1200 - 1200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000500830800100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'A consensus statement on the management of patients in outbreaks of methanol poisoning', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 424 - 425, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000468483300004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Development of national consensus recommendations for the management of colchicine poisoning by Poisons Information Centers', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 1028 - 1029, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449536500207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Effect of extracorporeal treatments in a patient with prolonged phenytoin toxicity', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 509 - 510, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399800900326&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Gastrointestinal toxicity and acute kidney injury following ingestion of suspected Amanita ochrophylla', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 505 - 505, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399800900316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Prolonged toxicity from amphetamine and quetiapine following overdose in a patient also taking cobicistat', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 464 - 464, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399800900224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Severe toxicity following lamotrigine overdose: a review of calls to Australia's largest Poisons Information Centre', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 422 - 422, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399800900132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Extracorporeal treatments in poisonings from non-traditionally dialyzed drugs: a national study', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 773 - 773, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406384000164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Extracorporeal treatments in poisonings from non-traditionally dialyzed drugs: a single center experience', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 772 - 773, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406384000163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Multiphoton imaging for assessing renal disposition in acute kidney injury', in Proceedings of SPIE - The International Society for Optical Engineering, http://dx.doi.org/10.1117/12.2242964
,2015, 'Availability of Extracorporeal Treatments: a Worldwide Survey', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 732 - 732, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359883400210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Cost of Extracorporeal Treatments: a Worldwide Survey', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, pp. 707 - 707, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359883400156&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'EXTRACORPOREAL THERAPIES FOR THE ENHANCED ELIMINATION OF DABIGATRAN', in NEPHROLOGY, WILEY-BLACKWELL, pp. 36 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'RITUXIMAB-ASSOCIATED HYPOGAMMAGLOBULINAEMIA: INCIDENCE, OUTCOMES AND EFFECT OF DOSE IN PATIENTS WITH MULTI-SYSTEM AUTOIMMUNE DISEASE', in NEPHROLOGY, WILEY-BLACKWELL, pp. 64 - 64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700174&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'VARIABILITY IN THE MANAGEMENT OF LITHIUM POISONING', in NEPHROLOGY, WILEY-BLACKWELL, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700233&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'CLEARANCE OF ANTIBIOTICS BY HIGH AND LOW INTENSITY CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS', in INTENSIVE CARE MEDICINE, SPRINGER, SPAIN, Barcelona, pp. S200 - S200, presented at 23rd Annual Meeting of the European-Society-of-Intensive-Care-Medicine, SPAIN, Barcelona, 09 October 2010 - 13 October 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281679500459&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'ANTIBIOTIC STABILITY IN COMMERCIAL PERITONEAL DIALYSIS SOLUTIONS: INFLUENCE OF FORMULATION, STORAGE AND DURATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. 58 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'BIOMARKERS OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE PARAQUAT POISONING', in NEPHROLOGY, WILEY-BLACKWELL, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'CLEARANCE OF ANTIBIOTICS BY HIGH AND LOW INTENSITY CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700233&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'LEAD MOBILISATION STUDY IN A PATIENT WITH END STAGE RENAL FAILURE ON HAEMODIALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'RIBAVIRIN THERAPEUTIC DRUG MONITORING IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEPATITIS C', in NEPHROLOGY, WILEY-BLACKWELL, pp. 76 - 76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700191&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'PROLONGED ELIMINATION OF EVEROLIMUS IN A RENAL TRANSPLANT PATIENT WITH SYSTEMIC OEDEMA', in NEPHROLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A53 - A54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270272500199&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,